December 4, 2024 8:01am
Record highs, inflation, interest rates, economics and Friday’s job report are supportive of a risk-on bias; yet … a show of exhaustion?
My interpretation of the morning’s numbers is written to be informative; it’s built on what happened or will happen behind the headline today!
MY Pre-Open Thoughts: 1 Negative, 1 Sell into Strength and 3 positive Indications
Never leave an investor uninform
Remember that overnight and pre-open actions’ futures and markets doesn’t necessarily translate into actual trading in today’s market session.
My interpretation of the morning’s numbers is written to be informative; it’s built on what happened or will happen behind the headline today!
Tuesday’s night’s … RegMed Investors (RMi) Closing Bell: as compared to Monday, a wipeout … https://www.regmedinvestors.com/articles/13719
Wednesday: The pre-open Dow futures are UP +38% or (+169 points), the S&P futures are UP 0.28% or (+17 points) and the Nasdaq futures are UP +0.65% or (+137 points)
- Stock futures rose Wednesday,
- European stocks were trading higher,
- Asia pacific markets were trading lower.
Henry’omics: We need to more than consider the economic environment to comprehend the micro re “our” universe of cell and gene therapy companies
Tuesday: The Dow closed DOWN -76.47 points or -0.17%, the S&P closed UP +2.73 points or +0.05% while the Nasdaq closed UP +76.96 points or +0.40% after Monday’s Dow closed DOWN -128.65 points or -0.29%, the S&P closed UP +14.77 points or +0.24% while the Nasdaq closed UP +185.78 points or +0.97%
Tuesday’s advance/decline line ended with a negative close at the close of 4 incliner, 30 decliners and 1 flat after Monday’s advance/decline line ended with a positive close at the close of 25 incliner, 9 decliners and 1 flat
Economic Data Docket: MBA Mortgage Applications, week ended Nov. 29 (+6.3% previously); ADP Private Payrolls, November (+165,000 expected, +233,000 previously); S&P Global US Services PMI, November final (57 previously), S&P Global US Composite PMI, November final (55.3 previously); ISM Services index, November (55.5 expected, 56 previously); ISM Services prices paid, November (58.1 previously); Factory orders, October (0.3% expected, -0.5% previously); Durable goods orders, October final (+0.2% previously)
Q4/24: 1 negative and 1 positive close
- November 10 negative and 9 positive closes
- October: 8 positive and 15 negative closes
Companies in my headlights – It’s your decision; I provide ideas and context
I post about “indication intelligence” looking toward investment conferences … to assist investors with insight into sector vulnerabilities and strengths.
A dictionary definition of “indicate” refers to something less than a certainty; an indication could be a signal of being oversold or overbought, a recommendation, or grounds for inferring or a basis for believing.
Sell into Strength:
Tuesday, Monday, Friday, Thursday and last Wednesday’s closing “numbers” with aftermarket/pre-market dollar ($) and cent ($0.00) value and percentage (%)
Mesoblast (MESO) closed up +$0.23 with a positive +$0.55 or +4.58% aftermarket
Positive Indications:
Tuesday, Monday, Friday, Thursday and last Wednesday’s closing “numbers” with aftermarket/pre-market dollar ($) and cent ($0.00) value and percentage (%)
CRISPR Therapeutics (CRSP down -$3.91 after Monday’s +$3.98, Friday’s +$0.33, Thursday and last Wednesday’s +$1.53 with a positive +$0.44 or +0.86% pre-open
Alnylam Pharmaceuticals (ALNY) closed down -$1.17 after Monday’s -$0.06, Friday’s -$0.67 with a positive +$0.96 or +0.38% pre-open
Vericel (VCEL) closed down -$0.50, after Tuesday’s +$0.60 and Friday’s +$0.38 with a positive +$1.13 or +1.94% pre-open
Negative Indications:
Tuesday, Monday, Friday, Thursday and last Wednesday’s closing “numbers” with aftermarket/pre-market dollar ($) and cent ($0.00) value and percentage (%)
MiMedx (MDXG) closed up +$0.17 after Monday’s +$0.13 and Friday’s -$0.18 with a negative -$0.10 or -1.05% aftermarket
The BOTTOM LINE: Trending or bending? …. A little bit of each!
I seem to be asking a question followed by a question …
- Do we need to brace ourself for more down share pricing slides
- Is this market STILL “bubblicious” my concerns are macroeconomic and valuation
Portfolio managers are addressing rotations as December “shakes” to years-end.
- I keep writing about uncertainty and skepticism … and coming realities.
- Even with the potential for some market hiccups along the way, the good news is Q4 has historically skewed positively, even as sector earnings kicked the bucket down the road!
Welcome to my world of defining the “grey’ in our universe!
- The sector is what it is, until it isn’t and even then, it doesn’t seem to be… as NOT much changes as the sector’s share pricing rides the waves of volatility, algorithms, electronic trading and short covering.
- I am more frequently right than consequentially wrong; if I wanted to be liked, I wouldn’t have been an analyst/journalist.
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice. All investments are subject to risks. Investors should consider investment objectives.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives. Regulation Analyst Certification (Reg AC): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and it’s or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.
Henry McCusker, the editor and publisher of RegMed Investors could hold or have positions securities referred to in this publication and he will NOTIFY investors of holdings.
